Added to YB: 2026-10-05
Pitch date: 2026-10-01
ICCC [bullish]
ImmuCell Corporation
+7.76%
current return
Author Info
No bio for this author
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$89.0M
Pitch Price
$9.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
12.32
P/E
131.42
EV/Sales
3.02
Sector
Biotechnology
Category
growth
Not So Fast - ImmuCell Corporation
ICCC (hold): ImmuCell’s mixed Q2 does not break the thesis: revenue rose 11.5%, including 27.7% U.S. growth, while value and volume share reached 38% and 19%. Lower manufacturing output, weaker mix and higher SG&A pressured margins, but easier backlog comparisons, salesforce contributions and an $8M plan to triple capacity over 18 months support the outlook at an estimated low-double-digit EV/2027 EBIT multiple.
Read full article (2 min)